Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Howard Marks, latest 13F

BioMarin Pharmaceutical

In Howard Marks's portfolio · Oaktree Capital Management

Ticker BMRN.CV

Still in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2026 Add 14% 64,025,000 0.9% $62.4M
Q1 2026 Add 33% 55,985,000 0.8% $54.0M
Q4 2025 Add 114% 42,118,000 0.6% $40.5M
Q3 2018 Reduce 28% 32,585,000 0.5% $36.7M
Q2 2018 Add 813% 45,150,000 0.7% $47.1M
Q4 2017 Add 6% 34,701,000 0.6% $40.4M
Q3 2017 Reduce 14% 32,754,000 0.6% $37.1M
Q2 2017 Add 18% 37,883,000 0.7% $42.6M
Q1 2017 Reduce 11% 32,163,000 0.5% $36.7M
Q4 2016 Reduce 5% 36,023,000 0.6% $40.8M
Q3 2016 Reduce 15% 38,073,000 0.6% $45.6M
Q2 2016 Add 10% 44,823,000 0.9% $49.9M
Q1 2016 Buy 40,810,000 0.9% $47.5M
Q1 2015 Reduce 48% 56,271,000 0.9% $84.4M
Q4 2014 Add 6% 107,846,000 1.4% $130.4M
Q3 2014 Add 8% 101,310,000 1.8% $110.8M
Q2 2014 Add 8% 94,050,000 1.7% $98.7M
Q1 2014 Add 56% 87,295,000 1.8% $97.1M
Q4 2013 Buy 56,000,000 1.1% $60.3M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.